Gillings School Directory

Juan M. Hincapie-Castillo, PharmD, PhD

Dr. Juan Hincapie-Castillo

Juan M. Hincapie-Castillo, PharmD, PhD

Assistant Professor
Department of Epidemiology
Center for Pharmacoepidemiology
Injury Prevention Research Center

Juan M. Hincapie-Castillo is an assistant professor at the Department of Epidemiology at the University of North Carolina at Chapel Hill. His research interests include 1) drug utilization and safety in pain management and psychotropic pharmacotherapy; 2) evaluation of the effects of law on health outcomes and policy surveillance (legal epidemiology); 3) assessment of health services utilization in pain management, substance use disorders, and chronic diseases; and 4) quality improvement and assessment of inpatient pain management and medication use.

Hincapie-Castillo previously served as an assistant professor in the Department of Pharmaceutical Outcomes & Policy at University of Florida. In 2021, he was appointed as a Research Fellow for the Center for Public Health Law Research (CPHLR) at Temple University.

Honors and Awards

Research Fellow

2021, Center for Public Health Law Research at Temple University

Emerging Leader

2020, International Society for Pharmacoepidemiology

New Investigator Award

2020, American Association of Colleges of Pharmacy

Keynote Speaker for Doctoral & Master's Commencement Summer

2020, University of Florida College of Pharmacy

Research Activities


Legal Epidemiology

Health Services Research

Drug Utilization Research

Pain Management


Service Activities

Associate Editor, Pharmacoepidemiology and Drug Safety Journal, 2021-Present

Science and Policy Advisor, National Pain Advocacy Center, 2020-Present 

Consultant, FDA’s Drug Safety and Risk Management Advisory Committee (DSaRM), 2020-Present

Key Publications

The effects of the Florida’s Opioid Restriction Law for Acute Pain on the Utilization of Prescription NSAID Medications. Keshwani S, Grande I, Maguire M, Vouri S, Goodin A, Hincapie-Castillo JM. (2021). JAMA Netw Open, 4(6).

Effects of Food and Drug Administration Removal of Indications for Use of Oral Quinolones. Tran PT, Antonelli P, Hincapie-Castillo JM, Winterstein A. (2021). JAMA Intern Med, 181(6), 808-816.

Changes in Prescribing by Provider Type Following a State Prescription Opioid Restriction Law. Valdes I, Possinger M, Hincapie-Castillo JM, Goodin A, Dewar M, Sumfest J, Vouri SM. (2021). J Gen Intern Med.
View publication

Impact of Injectable Opioid Restrictions during a Critical Drug Shortage Period: Interrupted Time Series for Institutional Opioid Utilization. Brokenshire S, Lemon SJ, Staley B, Voils A, Hincapie-Castillo JM. (2021). Pain Med, 22(2), 203-211.

Purchasing Drugs Abroad among US Cancer Survivors: Analysis of National Health Interview Survey 2011-2018. Hong Y, Xie Z, Gutter M, Odedina F, Hincapie-Castillo JM (2020). Am J Prev Med., S0749-3797(20), 30511-0.

Changes in Opioid Use After Florida’s Restriction Law for Acute Pain Prescriptions. Hincapie-Castillo JM, Goodin A, Possinger M, Usmani S, Vouri S. (2020). JAMA Netw Open, 3(2).


PhD, Pharmaceutical Sciences, University of Florida, 2019

MS, Pharmaceutical Sciences, University of Florida, 2017

PharmD, Pharmacy, University of Florida, 2013

Recent News